118 related articles for article (PubMed ID: 38862881)
21. Frequency of multi-drug resistance and mutations in Mycobacterium tuberculosis isolates from Punjab state of India.
Singhal R; Arora J; Sah GC; Bhalla M; Sarin R; Prasad Myneedu V
J Epidemiol Glob Health; 2017 Sep; 7(3):175-180. PubMed ID: 28756826
[TBL] [Abstract][Full Text] [Related]
22. Characterisation of drug resistance-associated mutations among clinical multidrug-resistant Mycobacterium tuberculosis isolates from Hebei Province, China.
Li Q; Wang Y; Li Y; Gao H; Zhang Z; Feng F; Dai E
J Glob Antimicrob Resist; 2019 Sep; 18():168-176. PubMed ID: 30926465
[TBL] [Abstract][Full Text] [Related]
23. Regional distribution of Mycobacterium tuberculosis infection and resistance to rifampicin and isoniazid as determined by high-resolution melt analysis.
Wang Z; Guo T; Jiang T; Zhao Z; Zu X; Li L; Zhang Q; Hou Y; Song K; Xue Y
BMC Infect Dis; 2022 Oct; 22(1):812. PubMed ID: 36316637
[TBL] [Abstract][Full Text] [Related]
24. Strong Increase in Moxifloxacin Resistance Rate among Multidrug-Resistant Mycobacterium tuberculosis Isolates in China, 2007 to 2013.
Xia H; Zheng Y; Liu D; Wang S; He W; Zhao B; Song Y; Ou X; Zhou Y; van den Hof S; Cobelens F; Zhao Y
Microbiol Spectr; 2021 Dec; 9(3):e0040921. PubMed ID: 34851179
[TBL] [Abstract][Full Text] [Related]
25. Multidrug-resistant Mycobacterium tuberculosis: a report of cosmopolitan microbial migration and an analysis of best management practices.
Joean O; Thiele T; Schütz K; Schwerk N; Sedlacek L; Kalsdorf B; Baumann U; Stoll M
BMC Infect Dis; 2020 Sep; 20(1):678. PubMed ID: 32942990
[TBL] [Abstract][Full Text] [Related]
26. Prevalence and molecular characterization of multidrug-resistant M. tuberculosis in Jiangxi province, China.
Luo D; Chen Q; Xiong G; Peng Y; Liu T; Chen X; Zeng L; Chen K
Sci Rep; 2019 May; 9(1):7315. PubMed ID: 31086215
[TBL] [Abstract][Full Text] [Related]
27. High incidence of drug-resistant Mycobacterium tuberculosis in Hainan Island, China.
Lin M; Zhong Y; Chen Z; Lin C; Pei H; Shu W; Pang Y
Trop Med Int Health; 2019 Sep; 24(9):1098-1103. PubMed ID: 31278806
[TBL] [Abstract][Full Text] [Related]
28. Whole-genome sequencing to characterize the genetic structure and transmission risk of
Ji L; Tao FX; Yu YF; Liu JH; Yu FH; Bai CL; Wan ZY; Yang XB; Ma J; Zhou P; Niu Z; Zhou P; Xiang H; Chen M; Xiang Z; Zhang FQ; Jiang Q; Liu XJ
Front Public Health; 2022; 10():1047965. PubMed ID: 36699912
[TBL] [Abstract][Full Text] [Related]
29. Epidemiological characteristics and risk factors of multidrug-resistant tuberculosis in Luoyang, China.
Wang Z; Hou Y; Guo T; Jiang T; Xu L; Hu H; Zhao Z; Xue Y
Front Public Health; 2023; 11():1117101. PubMed ID: 37228738
[TBL] [Abstract][Full Text] [Related]
30. Relatively low primary drug resistant tuberculosis in southwestern Ethiopia.
Abebe G; Abdissa K; Abdissa A; Apers L; Agonafir M; de-Jong BC; Colebunders R
BMC Res Notes; 2012 May; 5():225. PubMed ID: 22574696
[TBL] [Abstract][Full Text] [Related]
31. Detecting mutation pattern of drug-resistant Mycobacterium tuberculosis isolates in Himachal Pradesh using GenoType(®) MTBDRplus assay.
Thakur C; Kumar V; Gupta AK
Indian J Med Microbiol; 2015; 33(4):547-53. PubMed ID: 26470962
[TBL] [Abstract][Full Text] [Related]
32. Molecular characterization of multidrug-resistant Mycobacterium tuberculosis (MDR-TB) isolates identifies local transmission of infection in Kuwait, a country with a low incidence of TB and MDR-TB.
Al-Mutairi NM; Ahmad S; Mokaddas EM
Eur J Med Res; 2019 Dec; 24(1):38. PubMed ID: 31806020
[TBL] [Abstract][Full Text] [Related]
33. Correlations between drug resistance of Beijing/W lineage clinical isolates of Mycobacterium tuberculosis and sublineages: a 2009-2013 prospective study in Xinjiang province, China.
Wang XH; Ma AG; Han XX; Gu XM; Fu LP; Li PG; Li FY; Wang QZ; Liang H; Katar A; Wang LJ
Med Sci Monit; 2015 May; 21():1313-8. PubMed ID: 25950148
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of the frequency of mutation genes in multidrug-resistant tuberculosis (MDR-TB) strains in Beijing, China.
Liu Y; Sun Y; Zhang X; Zhang Z; Xing Q; Ren W; Yao C; Yu J; Ding B; Wang S; Li C
Epidemiol Infect; 2021 Jan; 149():e21. PubMed ID: 33397543
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of isoniazid resistance-conferring mutations associated with multidrug-resistant tuberculosis in Free State Province, South Africa.
Pitso L; Potgieter S; Van der Spoel van Dijk A
S Afr Med J; 2019 Aug; 109(9):659-664. PubMed ID: 31635590
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic accuracy and usefulness of the Genotype MTBDRplus assay in diagnosing multidrug-resistant tuberculosis in Cameroon? a cross-sectional study.
Abanda NN; Djieugoué JY; Lim E; Pefura-Yone EW; Mbacham WF; Vernet G; Penlap VM; Eyangoh SI; Taylor DW; Leke RGF
BMC Infect Dis; 2017 May; 17(1):379. PubMed ID: 28569148
[TBL] [Abstract][Full Text] [Related]
37. Increase in anti-tuberculosis drug resistance in Botswana: results from the fourth National Drug Resistance Survey.
Menzies HJ; Moalosi G; Anisimova V; Gammino V; Sentle C; Bachhuber MA; Bile E; Radisowa K; Kachuwaire O; Basotli J; Maribe T; Makombe R; Shepherd J; Kim B; Samandari T; El-Halabi S; Chirenda J; Cain KP
Int J Tuberc Lung Dis; 2014 Sep; 18(9):1026-33. PubMed ID: 25189548
[TBL] [Abstract][Full Text] [Related]
38. Performance of Biochip system in detecting drug resistant and multidrug-resistant tuberculosis using sputum collected from multiple clinical settings in Zhejiang, China.
Xu K; Wang S; Wu J; Liu Z; Ji Z; Zheng L; Jin X; Ren J; Yang S; Li Z; Yuan J; Zhao Y; Li L
Sci Rep; 2018 Jul; 8(1):10587. PubMed ID: 30002508
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of multidrug resistance in Mycobacterium tuberculosis isolates from HIV seropositive and seronegative patients with pulmonary tuberculosis in north India.
Sethi S; Mewara A; Dhatwalia SK; Singh H; Yadav R; Singh K; Gupta D; Wanchu A; Sharma M
BMC Infect Dis; 2013 Mar; 13():137. PubMed ID: 23497169
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of Multi-Drug Resistant Tuberculosis among Tuberculosis Patients Attending Chest Clinics in Osun-State, Nigeria.
Oyedeji GJ; Adeyemo C; Dissou A; Abiodun T; Alli OAT; Onaolapo OJ; Onaolapo AY; Adesiji Y; Olowe OA
Curr Pharm Biotechnol; 2020; 21(10):939-947. PubMed ID: 32101120
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
